Company: NDRA
Filing Date: 2025-07-16
Form Type: S-1/A
Source: 0001654954-25-008117
Chunk: 57

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-07-16
Form: S-1/A
Chunk 57
---
/24    |
| 21.1    |     | Subsidiaries of the Company                                                                                                 |                           |                |     | 10-K    |     |    21.1 |     | 03/30/22    |
| 23.1    |     | Consent of RBSM LLP, Independent Registered Public Accounting Firm                                                          |                           |                |     | S-1     |     |    23.1 |     | 07/08/25    |
| 23.2    |     | Consent of K&L Gates LLP (included in Exhibit 5.1)                                                                          |                           |                |     | S-1     |     |    23.2 |     | 07/08/25    |
| 24.1    |     | Power of Attorney (included on signature page)                                                                              |                           |                |     | S-1     |     |    24.1 |     | 07/08/25    |
| 107     |     | Filing Fee Table                                                                                                            |                           |                |     | S-1     |     |     107 |     | 07/08/25    |

* Indicates management compensatory plan, contract or arrangement

Item 17. Undertakings

The undersigned registrant hereby undertakes:

| (a) | The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant’s annual report pursuant to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.                                                                                                                                                                                                                                                                                                                                                                                                                  |
| (b) | Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (